Radix astragali and rhizoma Atractylodis macrocephalaein treating liver cirrhosis: A study based on data mining and network pharmacology
Year: 2026
Type: article
Abstract: This study applied data mining, network pharmacology, and molecular docking to investigate the prescribing patterns and mechanisms of the Radix Astragali–Rhizoma Atractylodis macrocephalaedrug pair in treating liver cirrhosis. Clinical prescriptions from the China Knowledge Network were analyzed for four qi, five flavors, and efficacy using the Chinese Medicine Inheritance Auxiliary Platform, with core drugs identified via association rule and cluster analyses. Network pharmacology identified 20 active ingredients linked to 93 targets, with key pathways including IL-17, PI3K-Akt, NF-κB, and VEGF. GO analysis indicated roles in gene expression, transcription regulation, apoptosis, survival, and angiogenesis. Molecular docking revealed kaempferol, formononetin, calycosin, and quercetin had strong binding affinities to core targets AKT1,TP53, IL-1β, and VEGFA. These findings suggest that the Radix Astragali–Rhizoma Atractylodis macrocephalaepair may exert therapeutic effects in liver cirrhosis through multi-target, multi-pathway mechanisms, providing a pharmacological basis for its clinical application.
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Keywords: liver cirrhosis, Astragalus membranaceus, Rhizoma Atractylodis Macrocephalae, traditional Chinese medicine, prescribing patterns, active ingredients, IL-17, PI3K/Akt signaling, NF-κB, vascular endothelial growth factor, angiogenesis, apoptosis, kaempferol, formononetin, calycosin, quercetin, AKT1, TP53, IL-1β, VEGF-A, multi-target multi-pathway mechanism
Open Access status: diamond
OpenAlex ID: W7208827282
